Testosterone Treatment Lawsuits Progress, With Issuance of New Order Governing Production of Electronically Stored Information, Bernstein Liebhard LLP Reports

Share Article

The Firm is evaluating testosterone lawsuits on behalf of men whose use of AndroGel and similar drugs allegedly caused heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other serious cardiovascular events.

Free Case Review
Our Firm is evaluating a number of testosterone lawsuits on behalf of men who were allegedly injured due to their use of testosterone replacement drugs. We are pleased that the federal litigation is preparing to move forward with discovery.

Hundreds of testosterone treatment (http://www.testosteronelawsuithub.com/) lawsuits filed against the manufacturers of AndroGel and similar medications continue to move forward in U.S. District Court, Northern District of Illinois, Bernstein Liebhard LLP reports. According to a Case Management Order dated November 6, 2014, the Court has established protocols for the production of electronically stored information for discovery. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“Our Firm is evaluating a number of testosterone lawsuits on behalf of men who were allegedly injured due to their use of testosterone replacement drugs. We are pleased that the federal litigation is preparing to move forward with discovery,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering free case reviews to victims of heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other life-threatening heart problems that were allegedly caused by prescription testosterone medication.

Testosterone Treatment Litigation
Testosterone treatment lawsuits have been mounting in U.S. courts since January, when the U.S. Food & Drug Administration (FDA) launched a safety review of their cardiovascular risks. According to court documents, more than 220 testosterone lawsuits are now pending in the litigation underway in Illinois, all of which claim that the manufacturers of low testosterone therapies failed to warn doctors and patients about their potential cardiovascular risks, and concealed those dangers from the public.

The FDA’s review of testosterone therapies is ongoing. In September, a panel of outside advisors convened by the FDA recommended that the manufacturers of the medications be required to conduct studies of their cardiovascular side effects. The advisors also recommended that the labeling for low testosterone therapies be revised to make clear they have not been shown to lessen low libido, fatigue, muscle loss and other symptoms typically associated with aging in men.*

Men who allegedly suffered a life-threatening cardiovascular event due to their use of AndroGel or other testosterone replacement medication may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*reuters.com/article/2014/09/17/us-usa-health-testosterone-idUSKBN0HC2C320140917, Reuters, September 18, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.testosteronelawsuithub.com/
https://plus.google.com/115936073311125306742?rel=author

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website